Related Experiment Video
Updated: Jun 2, 2026
SDS-PAGE/Immunoblot Detection of Aβ Multimers in Human Cortical Tissue Homogenates using Antigen-Epitope Retrieval
Published on: April 23, 2010
A universal method for detection of amyloidogenic misfolded proteins
Alice Y Yam1, Xuemei Wang, Carol Man Gao
1Novartis Vaccines and Diagnostics, Inc., 4560 Horton St., Emeryville, CA 94608, USA.
Abstract:
Diseases associated with the misfolding of endogenous proteins, such as Alzheimer's disease and type II diabetes, are becoming increasingly prevalent. The pathophysiology of these diseases is not totally understood, but mounting evidence suggests that the misfolded protein aggregates themselves may be toxic to cells and serve as key mediators of cell death. As such, an assay that can detect aggregates in a sensitive and selective fashion could provide the basis for early detection of disease, before cellular damage occurs. Here we report the evolution of a reagent that can selectively capture diverse misfolded proteins by interacting with a common supramolecular feature of protein aggregates. By coupling this enrichment tool with protein specific immunoassays, diverse misfolded proteins and sub-femtomole amounts of oligomeric aggregates can be detected in complex biological matrices. We anticipate that this near-universal approach for quantitative misfolded protein detection will become a useful research tool for better understanding amyloidogenic protein pathology as well as serve as the basis for early detection of misfolded protein diseases.
Insights
Researchers developed a novel assay to detect misfolded protein aggregates, crucial for understanding diseases like Alzheimer's. This tool enables sensitive and selective detection of toxic protein clumps, aiding early disease diagnosis.
Area of Science:
- Biochemistry and Molecular Biology
- Neurodegenerative Diseases
- Medical Diagnostics
Background:
- Protein misfolding diseases, including Alzheimer's disease and type II diabetes, are a growing global health concern.
- The exact mechanisms driving these diseases are unclear, but toxic protein aggregates are implicated in cellular damage and death.
- Sensitive and selective detection of these aggregates is critical for early diagnosis and intervention.
Purpose of the Study:
- To develop a novel reagent capable of selectively capturing diverse misfolded proteins.
- To establish a sensitive assay for detecting protein aggregates in complex biological samples.
- To provide a research tool for understanding amyloidogenic protein pathology and facilitating early disease detection.
Main Methods:
- Development of a reagent that targets a common supramolecular feature of protein aggregates.
- Coupling the enrichment reagent with protein-specific immunoassays.
- Testing the assay's ability to detect diverse misfolded proteins and oligomeric aggregates in complex biological matrices.
Main Results:
- Successful evolution of a reagent that selectively captures a wide range of misfolded proteins.
- Demonstration of the assay's capability to detect sub-femtomole amounts of oligomeric aggregates.
- Validation of the assay in complex biological matrices, indicating its practical applicability.
Conclusions:
- A near-universal approach for quantitative misfolded protein detection has been established.
- This assay serves as a valuable research tool for investigating amyloidogenic protein pathology.
- The developed method holds promise for the early detection of misfolded protein-associated diseases.
